• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMGEN USA, INC. ON-BODY INJECTOR FOR NEULASTA; INTRODUCER, SYRINGE NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMGEN USA, INC. ON-BODY INJECTOR FOR NEULASTA; INTRODUCER, SYRINGE NEEDLE Back to Search Results
Model Number 9002136
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/10/2024
Type of Reportable Event Malfunction
Event or Problem Description
Patient called following day stating red light flashing, chamber read full.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-BODY INJECTOR FOR NEULASTA
Common Device Name
INTRODUCER, SYRINGE NEEDLE
Manufacturer (Section D)
AMGEN USA, INC.
one amgen center drive
thousand oaks CA 91320
MDR Report Key19320283
Report Number19320283
Device Sequence Number20366399
Product Code KZH
Combination Product (Y/N)N
Initial Reporter StateMO
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type User Facility
Initial Reporter Occupation Risk Manager
Type of Report Initial
Report Date (Section B) 02/20/2024
Report Date (Section F) 02/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model Number9002136
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Date Report to Manufacturer05/15/2024
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date05/15/2024
Usage of Device Unknown
Patient Sequence Number1
Patient SexUnknown
Date Report Sent to FDA02/20/2024
-
-